Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Arch Gynecol Obstet ; 286(4): 931-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22692630

ABSTRACT

PURPOSE: We evaluated the role of the fossa ischioanalis (FI) in functional relations between the levator ani (LA) and gluteus maximus muscles (GM) in healthy female volunteers. METHODS: Twenty-three nulliparae were examined. Electromyogramms of LA and GM were simultaneously recorded during voluntary contraction of the pelvic floor muscles (PFM) and at rest in six body positions. The surface areas of LA (LAA), FI (FIA) and GM (GMA) were evaluated using MRI. RESULTS: Simultaneous LA and GM contractions were electromyographically observed irrespectively of body position in 97.2 %. MRI revealed synchronous movement of all structures: while LAA (-7.4 %) reduced, GMA increased (+6.8 %), FIA changed significantly (+3.4 %). CONCLUSIONS: The LA, FI and GM are morphologically and functionally connected. We recommend considering these structures as the 'LFG-Complex', emphasising the importance of this unit for functional integration of the pelvic floor. The findings of this study may contribute to understanding of urinary continence mechanism and disorders after pelvic floor surgery and obstetrical trauma.


Subject(s)
Muscle, Skeletal/physiology , Pelvic Floor/physiology , Adolescent , Adult , Buttocks/physiology , Electromyography , Female , Humans , Magnetic Resonance Imaging , Parity , Prospective Studies , Reference Values , Young Adult
2.
Arch Gynecol Obstet ; 276(3): 263-4, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17356827

ABSTRACT

We report the case of a 39-year-old woman who became pregnant despite a levonorgestrel-releasing intrauterine system (LNG-IUS), which was inserted 40 months before the pregnancy was detected. When a Caesarean section was performed, the LNG-IUS was found within the omentum majus. It has been reported, that displaced LNG-IUS can cause amenorrhea and high plasma levels of LNG in affected women, probably due to the higher resorptive capacity of the peritoneum, recommending a removal of the displaced LNG-IUS. Our case report demonstrates that a dislocated LNG-IUS does not necessary has the ability to suppress ovulation and therefore pregnancy. Therefore, every gynaecologist should be aware of a pregnancy despite a dislocated LNG-IUS.


Subject(s)
Foreign-Body Migration , Intrauterine Devices, Medicated , Levonorgestrel , Pregnancy, Unplanned , Adult , Cesarean Section , Contraceptive Agents, Female , Female , Humans , Incidental Findings , Infant, Newborn , Omentum , Pregnancy , Pregnancy Outcome
3.
Bone ; 40(2): 444-50, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16965947

ABSTRACT

The aim of this cross-sectional analysis was to examine the skeletal effects of low-dose monophasic oral contraceptive (OC) use in a cohort of 248 young Caucasian women aged 18-24 years. Areal bone mineral density (BMD) of the femoral neck and lumbar spine was evaluated by dual-energy X-ray absorptiometry. Volumetric BMD, bone mineral content (BMC), and bone geometry were assessed in the tibia by peripheral quantitative computed tomography (pQCT). The women were allocated into ever or never OC users, and also into 5 different OC groups according to duration and time of initiation of OC use. Women with >2 years of OC use and OC initiation within 3 years after menarche were characterized by 10% lower femoral neck areal BMD (P<0.001), 5% lower spine areal BMD (not significant, P=0.101), 7% lower distal tibial total BMC (P<0.05), and 6% lower total BMC at the tibial shaft (P<0.05) relative to never users. In addition, women who had ever used OCs had lower bone mass at the femoral neck and tibial shaft, despite similar age, height, weight, BMI, hours of exercise, and calcium intake compared with never users. At the tibial shaft, OC users showed reduced total cross-sectional area, and increased cortical BMD. In conclusion, our data suggest that OC use is associated with a detrimental effect on bone mass in young women, and provide further insight into the pathophysiological mechanisms involved.


Subject(s)
Bone Density/drug effects , Contraceptives, Oral/adverse effects , Femur Neck/drug effects , Lumbar Vertebrae/drug effects , Absorptiometry, Photon , Adolescent , Adult , Contraceptives, Oral/administration & dosage , Cross-Sectional Studies , Female , Femur Neck/diagnostic imaging , Humans , Lumbar Vertebrae/diagnostic imaging
4.
Arzneimittelforschung ; 52(9): 706-15, 2002.
Article in English | MEDLINE | ID: mdl-12404887

ABSTRACT

This randomised, double-blind, multicentric clinical study compared the efficacy and tolerability of the two vaginal antiseptics, 10 mg dequalinium chloride (CAS 522-51-0, Fluomycin N) and 200 mg povidone iodine (CAS 25655-41-8), in a parallel-group design. A total of 180 patients with vaginal infections of varying etiology participated in this study (bacterial vaginosis, fluor vaginalis, vulvo-vaginal candidiasis, trichomoniasis). Patients were randomly allocated to one of the two treatment groups and were treated once per day for 6 days. Control examinations took place 5 to 7 days after the end of treatment, and 3 to 4 weeks after the first control examination. The total symptoms score, a summary score for the clinical symptoms, discharge, burning, pruritus, redness of vulva/vagina, was defined as primary efficacy parameter. The treatments at the first control examination were compared in the full analysis set using the Wilcoxon-Mann-Whitney U-test, 2-sided, thereby proving equivalence of both treatments at the 5% level. Both treatments strongly improved the symptoms of vaginal infections both on short-term and long-term follow-up. Descriptive analysis of the secondary parameters, vaginal pH, degree of purity of the vaginal flora, and number of lactobacilli in the wet mounts, supported the comparable efficacy of both therapies to restore the vaginal milieu. Analysis of the diagnostic subgroups indicated that irrespective of the diagnosis, both treatments improved the efficacy criteria as observed for the entire population. The global assessment of the therapeutic efficacy by investigators and patients supported the results of the efficacy analysis with good to very good ratings in 70-90% of the cases. A good tolerability of both preparations was observed in this study with a low number of adverse events in the test group (5.8%).


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Dequalinium/therapeutic use , Povidone-Iodine/therapeutic use , Vaginal Diseases/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/adverse effects , Candidiasis, Vulvovaginal/drug therapy , Candidiasis, Vulvovaginal/microbiology , Dequalinium/administration & dosage , Dequalinium/adverse effects , Double-Blind Method , Female , Humans , Hydrogen-Ion Concentration , Middle Aged , Povidone-Iodine/administration & dosage , Povidone-Iodine/adverse effects , Trichomonas Infections/drug therapy , Trichomonas Infections/microbiology , Vaginal Discharge/microbiology , Vaginal Diseases/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...